Clinical Trial Update: T-cell Depleted Hematopoietic Stem Cell Boosts Without Conditioning for Poor Marrow Graft Function Following Allogeneic Hematopoietic Stem Cell Transplantation [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating T-cell depleted hematopoietic stem cell boost without conditioning for poor marrow graft function after allogeneic HSCT was terminate…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematopoietic Stem Cell Transplant-related Complication
• Poor Marrow Graft Function

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Hematopoietic Stem Cell Transplant, Poor Marrow Graft Function | Phase 2 | Status: TERMINATED | Results posted: 2018-06-06